Vikramjit Khangoora

1.7k total citations · 1 hit paper
35 papers, 1.0k citations indexed

About

Vikramjit Khangoora is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Vikramjit Khangoora has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Vikramjit Khangoora's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Pulmonary Hypertension Research and Treatments (12 papers) and Transplantation: Methods and Outcomes (11 papers). Vikramjit Khangoora is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Pulmonary Hypertension Research and Treatments (12 papers) and Transplantation: Methods and Outcomes (11 papers). Vikramjit Khangoora collaborates with scholars based in United States, France and South Korea. Vikramjit Khangoora's co-authors include Paul E. Marik, John D. Catravas, Michael H. Hooper, Christopher S. King, Nektarios Barabutis, Steven D. Nathan, Oksana A. Shlobin, Abhimanyu Chandel, Alison Brown and Mehul Desai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Vikramjit Khangoora

26 papers receiving 976 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock

2016 579 citations Paul E. Marik, Vikramjit Khangoora et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vikramjit Khangoora United States	11	428	323	288	215	153	35	1.0k
Takuhiro Moromizato United States	16	408 1.0×	216 0.7×	148 0.5×	194 0.9×	84 0.5×	33	1.1k
Jan Mehrtens New Zealand	7	276 0.6×	102 0.3×	436 1.5×	229 1.1×	45 0.3×	7	954
Mahmoud Barbarawi United States	16	149 0.3×	186 0.6×	102 0.4×	88 0.4×	68 0.4×	67	985
Santo Morabito Italy	22	93 0.2×	196 0.6×	178 0.6×	148 0.7×	61 0.4×	74	1.3k
Jasperina Dubois Belgium	17	960 2.2×	619 1.9×	370 1.3×	185 0.9×	170 1.1×	38	1.8k
Hiroyuki Ohbe Japan	15	128 0.3×	266 0.8×	216 0.8×	241 1.1×	61 0.4×	154	1.0k
E. Vincent S. Faustino United States	22	137 0.3×	356 1.1×	152 0.5×	324 1.5×	32 0.2×	89	1.5k
Russell B. Hawkins United States	17	64 0.1×	128 0.4×	250 0.9×	308 1.4×	62 0.4×	34	967
Yazan Zayed United States	16	167 0.4×	176 0.5×	119 0.4×	86 0.4×	22 0.1×	52	899
Giacomo Monti Italy	15	67 0.2×	316 1.0×	119 0.4×	99 0.5×	322 2.1×	47	944

Countries citing papers authored by Vikramjit Khangoora

Since Specialization

Citations

This map shows the geographic impact of Vikramjit Khangoora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikramjit Khangoora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikramjit Khangoora more than expected).

Fields of papers citing papers by Vikramjit Khangoora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikramjit Khangoora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikramjit Khangoora. The network helps show where Vikramjit Khangoora may publish in the future.

Co-authorship network of co-authors of Vikramjit Khangoora

This figure shows the co-authorship network connecting the top 25 collaborators of Vikramjit Khangoora. A scholar is included among the top collaborators of Vikramjit Khangoora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikramjit Khangoora. Vikramjit Khangoora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nathan, Steven D., Ho Cheol Kim, Christopher S. King, et al.. (2025). Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant. American Journal of Respiratory and Critical Care Medicine. 211(6). 984–991.

King, Christopher S., Rosalinda V. Ignacio, Vikramjit Khangoora, et al.. (2024). Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry. American Journal of Respiratory and Critical Care Medicine. 210(6). 801–813. 3 indexed citations

Wilkinson, James D., Sajal D. Tanna, C. Thomas, et al.. (2024). Delayed Presentation of Hyperammonemia Syndrome After Lung Transplant. The Journal of Heart and Lung Transplantation. 43(4). S480–S480.

Nathan, Steven D., Qiong Zhao, Dennis Kim, et al.. (2024). Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis. Pulmonary Circulation. 14(1). e12311–e12311. 3 indexed citations

Kim, Ho Cheol, Behnam Tehrani, Christopher S. King, et al.. (2024). Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease. SHILAP Revista de lepidopterología. 6. 100160–100160. 1 indexed citations

King, Christopher S., Emily White, Shambhu Aryal, et al.. (2023). Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry. Heliyon. 9(8). e18618–e18618. 2 indexed citations

Chandel, Abhimanyu, Christopher S. King, Shambhu Aryal, et al.. (2023). Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis. Pulmonary Circulation. 13(2). e12228–e12228. 2 indexed citations

Khangoora, Vikramjit, Elana J. Bernstein, Christopher S. King, & Oksana A. Shlobin. (2023). Connective tissue disease‐associated pulmonary hypertension: A comprehensive review. Pulmonary Circulation. 13(4). e12276–e12276. 13 indexed citations

Chandel, Abhimanyu, Christopher S. King, Rosalinda V. Ignacio, et al.. (2023). External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis. ERJ Open Research. 9(3). 124–2023. 10 indexed citations

10.

Chandel, Abhimanyu, et al.. (2021). Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation. Journal of Intensive Care Medicine. 36(6). 689–695. 24 indexed citations

11.

Chandel, Abhimanyu, Vikramjit Khangoora, Steven D. Nathan, et al.. (2021). Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension. Pulmonary Circulation. 11(2). 1–10. 5 indexed citations

12.

Pastré, Jean, Scott D. Barnett, Nesrin Moğulkoç, et al.. (2021). Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 18(11). 1803–1810. 1 indexed citations

13.

Pastré, Jean, Scott D. Barnett, Anne Brown, et al.. (2021). Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes. Respiratory Research. 22(1). 5–5. 11 indexed citations

14.

Ahmad, Kareem, Vikramjit Khangoora, & Steven D. Nathan. (2021). Lung Disease–Related Pulmonary Hypertension. Cardiology Clinics. 40(1). 77–88. 3 indexed citations

15.

Chandel, Abhimanyu, Alison Brown, A.C. Collins, et al.. (2020). High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success. Respiratory Care. 66(6). 909–919. 113 indexed citations

16.

King, Christopher S., Alison Brown, Erik Osborn, et al.. (2020). Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS ONE. 15(11). e0242651–e0242651. 68 indexed citations

17.

Khangoora, Vikramjit & Michael Eggert. (2019). Lenalidomide Induced Eosinophilic Pneumonia. A6276–A6276.

18.

Khangoora, Vikramjit, et al.. (2019). A Review of the Pulmonary and Health Impacts of Hookah Use. Annals of the American Thoracic Society. 16(10). 1215–1219. 12 indexed citations

19.

Barabutis, Nektarios, Vikramjit Khangoora, Paul E. Marik, & John D. Catravas. (2017). Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction. CHEST Journal. 152(5). 954–962. 92 indexed citations

20.

Khangoora, Vikramjit, Matthew McLaughlin, & Joshua Sill. (2015). A Case of Reexpansion Pulmonary Edema After Resection of a Large Teratoma, Treated With Extracorporeal Membrane Oxygenation. CHEST Journal. 148(4). 281A–281A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact